As observed for the T cell-competent mice in above studies, T cell-depleted control mice challenged with EBOV GP/rVSV succumbed to infection between 4–6 days, whereas T cell-depleted TIM-1-/- mice had significantly better survival (Fig 5B). This evidence concerns the gene HAVCR1 and infection.